NCT03398668View on ClinicalTrials.gov

Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

February 22, 2018

Primary Completion Date

December 30, 2018

Study Completion Date

December 30, 2018

Conditions
Migraine
Interventions
DEVICE

Relievion device- Treatment stimulation

1 Hour self-administered treatment specific occipital and supraorbital transcutaneous nerve stimulation

DEVICE

Relievion Device- Sham stimulation

1 Hour self-administered sham occipital and supraorbital transcutaneous nerve stimulation

Trial Locations (1)

Unknown

Laniado Medcial Center, Netanya

Sponsors

Lead Sponsor

Neurolief Ltd.
All Listed Sponsors
lead

Neurolief Ltd.

INDUSTRY

NCT03398668 - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migraine | Biotech Hunter | Biotech Hunter